226 related articles for article (PubMed ID: 30620752)
1. Human polyomavirus BKV infection of endothelial cells results in interferon pathway induction and persistence.
An P; Sáenz Robles MT; Duray AM; Cantalupo PG; Pipas JM
PLoS Pathog; 2019 Jan; 15(1):e1007505. PubMed ID: 30620752
[TBL] [Abstract][Full Text] [Related]
2. Cultured Renal Proximal Tubular Epithelial Cells Resemble a Stressed/Damaged Kidney While Supporting BK Virus Infection.
An P; Sáenz Robles MT; Cantalupo PG; Naik AS; Sealfon R; Imperiale MJ; Pipas JM
J Virol; 2023 May; 97(5):e0034323. PubMed ID: 37166336
[TBL] [Abstract][Full Text] [Related]
3. BK Polyomavirus: Clinical Aspects, Immune Regulation, and Emerging Therapies.
Ambalathingal GR; Francis RS; Smyth MJ; Smith C; Khanna R
Clin Microbiol Rev; 2017 Apr; 30(2):503-528. PubMed ID: 28298471
[TBL] [Abstract][Full Text] [Related]
4. Primary Human Renal-Derived Tubular Epithelial Cells Fail to Recognize and Suppress BK Virus Infection.
de Kort H; Heutinck KM; Ruben JM; Ede V Silva A; Wolthers KC; Hamann J; Ten Berge IJM
Transplantation; 2017 Aug; 101(8):1820-1829. PubMed ID: 27755502
[TBL] [Abstract][Full Text] [Related]
5. Different behaviour of BK-virus infection in liver transplant recipients.
Umbro I; Tinti F; Muiesan P; Mitterhofer AP
World J Gastroenterol; 2016 Jan; 22(4):1532-40. PubMed ID: 26819520
[TBL] [Abstract][Full Text] [Related]
6. Interaction Between Human Polyomavirus BK and Hypoxia Inducible Factor-1 alpha.
Signorini L; Croci M; Boldorini R; Varella RB; Elia F; Carluccio S; Villani S; Bella R; Ferrante P; Delbue S
J Cell Physiol; 2016 Jun; 231(6):1343-9. PubMed ID: 26529465
[TBL] [Abstract][Full Text] [Related]
7. Viral Origin, Clinical Course, and Renal Outcomes in Patients With BK Virus Infection After Living-Donor Renal Transplantation.
Schwarz A; Linnenweber-Held S; Heim A; Framke T; Haller H; Schmitt C
Transplantation; 2016 Apr; 100(4):844-53. PubMed ID: 26720302
[TBL] [Abstract][Full Text] [Related]
8. Fluoroquinolones inhibit human polyomavirus BK (BKV) replication in primary human kidney cells.
Sharma BN; Li R; Bernhoff E; Gutteberg TJ; Rinaldo CH
Antiviral Res; 2011 Oct; 92(1):115-23. PubMed ID: 21798289
[TBL] [Abstract][Full Text] [Related]
9. Single-Cell Transcriptomics Reveals a Heterogeneous Cellular Response to BK Virus Infection.
An P; Cantalupo PG; Zheng W; Sáenz-Robles MT; Duray AM; Weitz D; Pipas JM
J Virol; 2021 Feb; 95(6):. PubMed ID: 33361432
[TBL] [Abstract][Full Text] [Related]
10. Human polyomavirus type 1 (BK virus) agnoprotein is abundantly expressed but immunologically ignored.
Leuenberger D; Andresen PA; Gosert R; Binggeli S; Ström EH; Bodaghi S; Rinaldo CH; Hirsch HH
Clin Vaccine Immunol; 2007 Aug; 14(8):959-68. PubMed ID: 17538118
[TBL] [Abstract][Full Text] [Related]
11. Outcome of renal transplant recipients with cytomegalovirus and BK polyomavirus co-infection nephropathy.
Kaul A; Kumar S; Bhaduaria D; Agrawal V; Sharma RK; Prasad N; Gupta A; Kumar R
Saudi J Kidney Dis Transpl; 2018; 29(1):101-106. PubMed ID: 29456214
[TBL] [Abstract][Full Text] [Related]
12. 1-O-hexadecyloxypropyl cidofovir (CMX001) effectively inhibits polyomavirus BK replication in primary human renal tubular epithelial cells.
Rinaldo CH; Gosert R; Bernhoff E; Finstad S; Hirsch HH
Antimicrob Agents Chemother; 2010 Nov; 54(11):4714-22. PubMed ID: 20713664
[TBL] [Abstract][Full Text] [Related]
13. Polyomavirus infection in pediatric renal transplant recipients: evaluation using a quantitative real-time PCR technique.
Herman J; Van Ranst M; Snoeck R; Beuselinck K; Lerut E; Van Damme-Lombaerts R
Pediatr Transplant; 2004 Oct; 8(5):485-92. PubMed ID: 15367285
[TBL] [Abstract][Full Text] [Related]
14. Interplay of cellular and humoral immune responses against BK virus in kidney transplant recipients with polyomavirus nephropathy.
Chen Y; Trofe J; Gordon J; Du Pasquier RA; Roy-Chaudhury P; Kuroda MJ; Woodle ES; Khalili K; Koralnik IJ
J Virol; 2006 Apr; 80(7):3495-505. PubMed ID: 16537617
[TBL] [Abstract][Full Text] [Related]
15. Involvement of cytoskeletal components in BK virus infectious entry.
Eash S; Atwood WJ
J Virol; 2005 Sep; 79(18):11734-41. PubMed ID: 16140751
[TBL] [Abstract][Full Text] [Related]
16. Evolution of the BK polyomavirus: epidemiological, anthropological and clinical implications.
Yogo Y; Sugimoto C; Zhong S; Homma Y
Rev Med Virol; 2009 Jul; 19(4):185-99. PubMed ID: 19530118
[TBL] [Abstract][Full Text] [Related]
17. BK-VP3 as a new target of cellular immunity in BK virus infection.
Mueller K; Schachtner T; Sattler A; Meier S; Friedrich P; Trydzenskaya H; Hinrichs C; Trappe R; Thiel A; Reinke P; Babel N
Transplantation; 2011 Jan; 91(1):100-7. PubMed ID: 21452414
[TBL] [Abstract][Full Text] [Related]
18. Impact of a polyomavirus (BKV) infection on mRNA expression in human endothelial cells.
Grinde B; Gayorfar M; Rinaldo CH
Virus Res; 2007 Jan; 123(1):86-94. PubMed ID: 16996634
[TBL] [Abstract][Full Text] [Related]
19. BK polyomavirus microRNA expression and sequence variation in polyomavirus-associated nephropathy.
Virtanen E; Seppälä H; Helanterä I; Laine P; Lautenschlager I; Paulin L; Mannonen L; Auvinen P; Auvinen E
J Clin Virol; 2018 May; 102():70-76. PubMed ID: 29518695
[TBL] [Abstract][Full Text] [Related]
20. Polyomavirus T antigens activate an antiviral state.
Giacobbi NS; Gupta T; Coxon AT; Pipas JM
Virology; 2015 Feb; 476():377-385. PubMed ID: 25589241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
